These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
511 related articles for article (PubMed ID: 31747090)
1. Constructing and deconstructing the bacterial cell wall. Fisher JF; Mobashery S Protein Sci; 2020 Mar; 29(3):629-646. PubMed ID: 31747090 [TBL] [Abstract][Full Text] [Related]
2. The threat of antibiotic resistance in Gram-negative pathogenic bacteria: beta-lactams in peril! Thomson JM; Bonomo RA Curr Opin Microbiol; 2005 Oct; 8(5):518-24. PubMed ID: 16126451 [TBL] [Abstract][Full Text] [Related]
3. Discovery of a new class of non-β-lactam inhibitors of penicillin-binding proteins with Gram-positive antibacterial activity. O'Daniel PI; Peng Z; Pi H; Testero SA; Ding D; Spink E; Leemans E; Boudreau MA; Yamaguchi T; Schroeder VA; Wolter WR; Llarrull LI; Song W; Lastochkin E; Kumarasiri M; Antunes NT; Espahbodi M; Lichtenwalter K; Suckow MA; Vakulenko S; Mobashery S; Chang M J Am Chem Soc; 2014 Mar; 136(9):3664-72. PubMed ID: 24517363 [TBL] [Abstract][Full Text] [Related]
4. An overview of the response of bacteria to beta-lactam antibiotics. Greenwood D Rev Infect Dis; 1986; 8 Suppl 5():S487-95. PubMed ID: 3541134 [TBL] [Abstract][Full Text] [Related]
5. The sentinel role of peptidoglycan recycling in the β-lactam resistance of the Gram-negative Enterobacteriaceae and Pseudomonas aeruginosa. Fisher JF; Mobashery S Bioorg Chem; 2014 Oct; 56():41-8. PubMed ID: 24955547 [TBL] [Abstract][Full Text] [Related]
6. A multivalent approach to drug discovery for novel antibiotics. Long DD; Aggen JB; Christensen BG; Judice JK; Hegde SS; Kaniga K; Krause KM; Linsell MS; Moran EJ; Pace JL J Antibiot (Tokyo); 2008 Oct; 61(10):595-602. PubMed ID: 19168973 [TBL] [Abstract][Full Text] [Related]
7. Mechanisms of resistance and clinical relevance of resistance to β-lactams, glycopeptides, and fluoroquinolones. Rice LB Mayo Clin Proc; 2012 Feb; 87(2):198-208. PubMed ID: 22305032 [TBL] [Abstract][Full Text] [Related]
9. PBP Target Profiling by β-Lactam and β-Lactamase Inhibitors in Intact Pseudomonas aeruginosa: Effects of the Intrinsic and Acquired Resistance Determinants on the Periplasmic Drug Availability. Montaner M; Lopez-Argüello S; Oliver A; Moya B Microbiol Spectr; 2023 Feb; 11(1):e0303822. PubMed ID: 36475840 [TBL] [Abstract][Full Text] [Related]
10. New compounds for a good old class: Synthesis of two Β-lactam bearing cephalosporins and their evaluation with a multidisciplinary approach. Vigliotta G; Giordano D; Verdino A; Caputo I; Martucciello S; Soriente A; Marabotti A; De Rosa M Bioorg Med Chem; 2020 Feb; 28(4):115302. PubMed ID: 31932194 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of antimicrobial susceptibility for beta-lactams using the Etest method against clinical isolates from 100 medical centers in Japan (2006). Ishii Y; Tateda K; Yamaguchi K; Diagn Microbiol Infect Dis; 2008 Feb; 60(2):177-83. PubMed ID: 17931820 [TBL] [Abstract][Full Text] [Related]
12. The Penicillin-Binding Protein PbpP Is a Sensor of β-Lactams and Is Required for Activation of the Extracytoplasmic Function σ Factor σ Nauta KM; Ho TD; Ellermeier CD mBio; 2021 Mar; 12(2):. PubMed ID: 33758089 [TBL] [Abstract][Full Text] [Related]
13. Total Syntheses of Bulgecins A, B, and C and Their Bactericidal Potentiation of the β-Lactam Antibiotics. Tomoshige S; Dik DA; Akabane-Nakata M; Madukoma CS; Fisher JF; Shrout JD; Mobashery S ACS Infect Dis; 2018 Jun; 4(6):860-867. PubMed ID: 29716193 [TBL] [Abstract][Full Text] [Related]
14. MEN 10700, a new penem antibiotic: in-vitro activity and its correlation with beta-lactamase stability, PBP affinity and diffusion through the bacterial cell wall. Fontana R; Altamura M; Arcamone F; Mazzariol A; Morandotti G; Sperning R; Cornaglia G J Antimicrob Chemother; 1998 May; 41(5):513-25. PubMed ID: 9630405 [TBL] [Abstract][Full Text] [Related]
15. [Mechanism of action of beta-lactam antibiotics and the resistance of microorganisms]. Vakulenko SB Antibiot Med Biotekhnol; 1987 Apr; 32(4):294-302. PubMed ID: 3307609 [No Abstract] [Full Text] [Related]
16. Cell-wall recycling and synthesis in Escherichia coli and Pseudomonas aeruginosa - their role in the development of resistance. Dhar S; Kumari H; Balasubramanian D; Mathee K J Med Microbiol; 2018 Jan; 67(1):1-21. PubMed ID: 29185941 [TBL] [Abstract][Full Text] [Related]
17. Characterization of a novel small molecule that potentiates β-lactam activity against gram-positive and gram-negative pathogens. Nair DR; Monteiro JM; Memmi G; Thanassi J; Pucci M; Schwartzman J; Pinho MG; Cheung AL Antimicrob Agents Chemother; 2015 Apr; 59(4):1876-85. PubMed ID: 25583731 [TBL] [Abstract][Full Text] [Related]
18. [Progress in regulatory mechanism for inducing β-lactamase in Gram-negative bacteria]. Xu C; Zhang T; Cai J; Yu Z; Qiu J; Yin J Sheng Wu Gong Cheng Xue Bao; 2018 Aug; 34(8):1288-1296. PubMed ID: 30152214 [TBL] [Abstract][Full Text] [Related]
19. [Antibacterial activity of sulopenem, a new parenteral penem antibiotic]. Inoue E; Komoto E; Taniyama Y; Mitsuhashi S Jpn J Antibiot; 1996 Apr; 49(4):338-51. PubMed ID: 8786625 [TBL] [Abstract][Full Text] [Related]
20. Muropeptides in Pseudomonas aeruginosa and their Role as Elicitors of β-Lactam-Antibiotic Resistance. Lee M; Dhar S; De Benedetti S; Hesek D; Boggess B; Blázquez B; Mathee K; Mobashery S Angew Chem Int Ed Engl; 2016 Jun; 55(24):6882-6. PubMed ID: 27111486 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]